From: Molecular characterization of EGFR, PDGFRA and VEGFR2 in cervical adenosquamous carcinoma
Case | Age | Disease recurrence | Presence of metastasis* | Follow-up (months) | Life status |
---|---|---|---|---|---|
1 | 41 | No | No | 64 | Alive |
2 | 37 | No | Yes | 22 | Alive |
3 | 55 | NI | NI | NI | NI |
4 | 59 | No | Yes | 16 | Dead |
5 | 46 | No | No | 107 | Alive |
6 | 27 | No | No | 28 | Alive |
7 | 33 | Yes | No | 36 | Alive |
8 | 67 | No | No | 34 | Alive |
9 | 40 | No | No | 35 | Alive |
10 | 54 | No | Yes | 48 | Dead |
11 | 57 | Yes | No | 30 | Alive |
12 | 61 | No | No | 9 | Alive |
13 | 67 | No | No | 32 | Alive |
14 | 38 | No | No | 17 | Alive |
15 | 71 | No | No | 5 | Alive |
16 | 40 | No | No | 87 | Alive |
17 | 40 | No | No | 10 | Alive |
18 | 58 | No | Yes | 47 | Dead |
19 | 47 | No | No | 22 | Alive |
20 | 41 | No | No | 14 | Alive |
21 | 39 | No | Yes | 9 | Dead |
22 | 40 | No | Yes | 48 | Alive |
23 | 45 | No | No | 35 | Alive |
24 | 53 | No | Yes | 13 | Alive |
25 | 29 | No | Yes | 14 | Dead |
26 | 36 | No | Yes | 19 | Dead |
27 | 24 | No | Yes | 6 | Alive |
28 | 48 | No | Yes | NI | Dead |
29 | 56 | No | No | 22 | Alive |
30 | 77 | No | Yes | 17 | Alive |